Does Exercise Boost Your Immune System? The Immunity Audit: What Training Actually Does to Your Defense System, the J-Curve That Began with the Los Angeles Marathon's 5.9× Week, the Open-Window Theory the Bath Group Demolished, the Postmenopausal RCT That Cut Colds Threefold, the Vaccination-Adjuvant File, and the Elite-Athlete Paradox Where Fewer Than 30% of the Illnesses Carry a Pathogen
Every gym holds two immunity camps, and both are certain. Camp one pops their vitamin C, avoids the "germ-ridden" cardio theatre on principle, and believes any training beyond a gentle stroll quietly bankrupts the immune system — that every hard session opens a door viruses walk through. Camp two hasn't been sick since they started training and credits the streak entirely to the barbell: iron builds the wall, colds are for the sedentary. Both camps quote the same marathon-running uncle. Neither has read the file — and the file is the best soap opera in exercise science: a founding study with a terrifying number, a J-shaped curve everyone learned, a decades-long "open window" theory, and a 2018 demolition job that rewrote what the numbers after a hard session even mean. This library has cross-examined the neighbours — what training does to blood pressure, to blood sugar, to cholesterol, to mood — but never the defense system itself. Does exercise boost your immune system — or quietly spend it? Where does the benefit peak, what does a genuinely hard session do for the next day, and which camp does the evidence actually send home?
The evidence answers in three acts. Act one is the dose curve: regular moderate training reduces infection risk — in the best randomized trial, a year of 45-minute moderate sessions cut cold risk so hard that in the final quarter the sedentary stretchers caught colds at more than three times the rate of the exercisers [10]. Act two is the paradox at the extremes: in the founding cohort, runners who finished the Los Angeles Marathon reported infectious episodes in the following week at odds 5.9× those of equally experienced runners who didn't race — 12.9% versus 2.2% [1] — and elite athletes carry illness burdens second only to injury [9]. Act three is the revision: the Bath group's 2018 demolition argued the famous post-exercise "immune suppression" was largely a redistribution — immune cells moving to the tissues where they patrol, a heightened state of surveillance, not a collapse — and that vaccination studies show exercise amplifying immune responses [7]. Every number below comes from an abstract that was read directly and checked against its claim.
The short answer: yes — and the curve is shaped like a J
Strip the folklore and the claim "exercise boosts immunity" has a checkable shape. If it's true, trained groups should fall ill less than sedentary ones; the benefit should follow a dose; pushing the dose far enough should eventually cost something (or not); and the immune system should show measurable changes in the right direction.
The model that organized thirty years of research drew the whole answer in one character: the J-curve [2]. The field's own retrospective — from 1980s cell counts through the heavy-exertion era to today's systems-biology tools — reads the same arc [8]. Picture sedentary people on the tall arm of the J — average infection risk. Slide down to moderate training and risk falls below the sedentary baseline: the dip of the J. Keep climbing to heavy chronic training and marathon-type exertion, and risk rises again — past the baseline, up the short arm. The 1994 review that formalized it put the peak-danger window precisely: risk "especially high during the one or 2-wk period following marathon-type race events," while "moderate amounts of exercise may decrease one's risk" through favourable immune changes without the stress-hormone toll of heavy exertion [2].
Both camps in the gym-opening paragraph are therefore reading one arm of the same letter. Camp one quotes the short arm — the post-marathon week — and generalizes it to every training session; camp two quotes the dip and pretends the short arm doesn't exist. The audit's job is to price each arm honestly: how big is the dip, how real is the climb, and what actually causes it.
The founding cohort: the week after the marathon
The number that started the field came from the 1987 Los Angeles Marathon. Eight days before the race, researchers surveyed a random sample of the 12,200 applicants; 2,311 runners responded, reporting infectious episodes, training volumes and race participation [1]. Two findings landed in every textbook. First, the race itself: among the 1,828 participants who arrived healthy, 12.9% reported an infectious episode during the following week, versus 2.2% of the 134 equally experienced runners who had applied but didn't race — an odds ratio of 5.9 (95% CI 1.9–18.8) [1]. Second, the training volume: in the two months before the race, runners logging ≥97 km a week carried double the infectious-episode odds of those under 32 km a week — OR 2.0 (1.2–3.4), with a significant dose–response trend across the six volume categories [1].
Honesty tags, because this study carries the field's biggest caveat: it is observational, self-reported, and from an era before a single nasal swab confirmed anything. The respondents were two years older and seven minutes faster than the average finisher [1]; sick runners may remember and report differently; and "infectious episode" meant what the runner believed it to mean. The 5.9× is real data, not a randomized truth — and what the illness episodes actually were is the question the field spent the next twenty years unpacking (the answer, below, is stranger than either camp expects).
The open window: what heavy sessions actually do for 3–24 hours
The mechanism story that explained the marathon week became textbook immunology: after prolonged strenuous exercise, several immune functions dip for a few hours — the "open window" in which pathogens were supposed to slip through. The cleanest statement of it remains the 2007 synthesis: prolonged bouts cause "a temporary depression of various aspects of immune function (e.g., neutrophil respiratory burst, lymphocyte proliferation, monocyte antigen presentation) that usually lasts approximately 3–24 h after exercise" — most pronounced when the session is continuous, longer than 1.5 hours, at 55–75% of maximum oxygen uptake, and performed without food, and stretched further by periods of intensified training lasting a week or more [3].
But the same paper carries the two sentences that keep the window honest. First: "elite athletes are not clinically immune deficient" [3] — the dips are lab-range shifts in people whose baseline surveillance is excellent, not a door thrown open. Second, the causal chain is confounded by everything that travels with heavy training: the elite athlete's illness burden reflects travel, exposure, sleep disruption and stress alongside the sessions themselves [3][9]. The window is real as a measurement; whether it is real as an entrance for infection is exactly what the next act demolishes.
The demolition job: redistribution, not suppression
In 2018, two researchers from the University of Bath walked through the open-window theory pillar by pillar and published the teardown under a title that left nothing to the imagination — Debunking the Myth of Exercise-Induced Immune Suppression [7]. Their three-point indictment: limited reliable evidence exists that vigorous exercise heightens risk of opportunistic infections at all; the post-exercise fall in lymphocyte counts and the dips in salivary IgA do not signpost a period of immune suppression; and the dramatic 1–2-hour lymphopenia after hard bouts "reflects a transient and time-dependent redistribution of immune cells to peripheral tissues, resulting in a heightened state of immune surveillance and immune regulation, as opposed to immune suppression" [7].
On the positive side of the ledger, the same review assembled the evidence that frequent exercise enhances immune competence: human vaccination studies show heightened responses to bacterial and viral antigens following bouts of exercise, and regular physical activity across the lifespan appears to limit or delay aging of the immune system [7]. The reframing matters practically: the immune cells leaving the bloodstream after your hard session aren't deserting the walls — they're being redeployed to the tissues where infections actually begin. The field's own debate article would later state the settled part plainly: "regular bouts of short-lasting (i.e. up to 45 minutes) moderate intensity exercise is beneficial for host immune defense, particularly in older adults and people with chronic diseases" [9].
The peace treaty: the 2020 debate, and what stays contested
Because a demolition invites a counter-demolition, the field convened its own debate in 2020 — eight authors from both camps, including the Bath group and the marathon-era researchers, around one question: can exercise per se increase susceptibility to infection? [9]. The agreements are the treaty's text: moderate exercise benefits host defense, especially in older adults and people with chronic disease; infection burden in high-performance athletes is real and "second only to injury for the number of training days lost during preparation for major sporting events"; and infection susceptibility has "a multifactorial underpinning" — anxiety, sleep disruption, travel, pathogen exposure, nutritional deficits and environmental extremes activate the same immune pathways the training does [9].
What stays contested is the exact charge sheet against the sessions themselves: whether exercise independently of all those co-travellers raises infection risk, whether the standard biomarkers mean what the old model claimed, and how strong the evidence either way really is [9]. For the gym reader, the treaty translates to something refreshingly practical: the thing to manage is the whole load — training, sleep, travel, stress, food — not a mythical 24-hour lockdown after every hard set.
The RCT that counted colds
Observational curves and lab windows aside, the cleanest experiment in the file randomized 115 sedentary, overweight, postmenopausal women to a year of 45 minutes of moderate-intensity exercise five days a week or to weekly 45-minute stretching sessions, then counted colds quarterly for twelve months [10]. The result: cold risk fell in the exercisers relative to the stretchers (P = .02), and by the final three months the stretchers' cold risk was more than threefold the exercisers' (P = .03) [10].
The honesty tag is printed right in the abstract: overall upper-respiratory infection risk did not differ significantly between groups (P = .16), with a possible distortion from unequal influenza-vaccination rates between arms [10]. Read both lines together and the finding survives at exactly the right size — a moderate, walkable, year-long dose measurably reduced the commonest infection in the exact population (older, sedentary) the debate file flags as most responsive [9][10], without pretending one year of walking abolishes respiratory illness. The session-length question this library has audited for muscle has an immunity answer hiding in the protocol: the dose that worked was 45 minutes, moderate — almost precisely the "up to 45 minutes" the consensus names as the beneficial range [9][10].
The vaccination file: exercise as a behavioral adjuvant
The immune system's most objective report card is the vaccine response — a standardized antigen challenge with a standardized antibody readout — and here the file is almost embarrassingly favourable. The systematic review of the exercise-vaccination literature pooled twenty trials of acute or chronic exercise before vaccination and concluded that "most of the current published literature suggests that exposure to either acute or chronic exercise significantly augments the immune response to vaccination" [11].
The review's own caution keeps the celebration in proportion: the clinical importance of the adjuvant effect, the variability across cohorts, the dose–response relationship and the optimal modality all "deserve further study" [11]. But the direction is consistent, the endpoint is hard, and the demolition review read the same literature as "heightened responses to bacterial and viral antigens following bouts of exercise" [7]. An immune system that answers a vaccine louder in trained people is not a suppressed one — it is a better-crewed one.
The elite paradox: when the pathogen isn't there
Now the twist that rewrites the marathon week. Australian researchers ran prospective surveillance over five months of training and competition — 32 elite and 31 recreationally competitive triathletes and cyclists plus 20 sedentary controls — and swabbed every illness: microscopy, culture and PCR for typical and atypical respiratory pathogens [4]. The headline confirmed the J's short arm: the incidence-rate ratio for upper-respiratory illness was 4.50 (95% CI 1.91–10.59) in the elite athletes versus the recreational group (controls sat between at 1.93, 0.72–5.18) [4]. The footnote upended its meaning: pathogens were isolated in only 11 of 37 illness episodes — fewer than 30% — with rhinovirus the commonest find [4].
Fewer than a third of the athletes' "infections" had an infectious cause identified at all. The rest are presumed non-infectious airway inflammation — from cold dry air, pollutants, exercise-induced bronchoconstriction — and the symptom scores were indeed worst when a pathogen was found, peaking on illness days 3–4 [4]. Which means the gym's camp one has been half-right about the wrong mechanism: heavy training loads genuinely associate with more sick days in elite cohorts [4][9], but a large share of the "immune system failing" story is airway irritation wearing an infection's clothes — and treatment, as the authors note, should consider both [4].
The counterfile: what exercise's immune effect is not
- It is not a force field. The RCT cut colds, not colds to zero [10]; the marathon cohort's controls still caught only 2.2% in race week [1]. Training shifts the odds; it does not repeal exposure, sleep, or the kindergartener you live with.
- It is not linear. The J-curve is the model: moderate beats sedentary, and marathon-type loads ride back up the short arm in the weeks around the event [1][2]. More is better only until it isn't — the same shape as the recovery logic this library applies to muscle.
- It is not a demolition-zone after every session. The 3–24-hour dips are real measurements [3], but the modern reading is redistribution and heightened surveillance, not suppressed immunity [7] — and the consensus benefit range is regular, short, moderate sessions up to about 45 minutes [9].
- It is not cancelled by hard training. Elite athletes are not immunodeficient [3]; their illness burden is real but multifactorial — travel, sleep, exposure, stress ride the same pathways [9] — and fewer than a third of elite illness episodes even carry a pathogen [4].
- It is not a pill substitute or a vaccine replacement. Exercise augments vaccine responses [7][11]; it does not replace them — and immunocompromised readers or anyone returning after serious illness should route the plan through their clinician, not this file.
- It is not owned by supplements. Nothing in this file touches your vitamin drawer; the immunity lever measured here is training load, sleep and recovery — the boring stuff the two-part position statement actually prescribes [5][6].
How RightRep fits into this
The immunity file's actionable core — regular moderate sessions, load managed up gradually, rest built in, illness watched instead of trained through — is a programming problem, and programming problems are ledger problems:
- The J-curve is a load-management dashboard. The position statement's prescription is gradual periodized increases, variety over monotony, enforced rest and monitoring for deterioration, with alert windows around intensive weeks and competition [6]. A tracked training log is that monitor — progressive overload applied weekly instead of heroically.
- The beneficial dose is countable. "Short-lasting, up to 45 minutes, moderate intensity" [9] — the exact currency of a training log's session view, and the difference between the dip of the J and its short arm is visible in weekly volume numbers, not in feel.
- The streak worth protecting is the moderate one. The RCT's benefit came from five moderate sessions a week across a year [10] — the kind of sustainable frequency a camera-counted log keeps honest, with the sick-day rules already audited in this library for the weeks the ledger has to pause.
The bottom line
Does exercise boost your immune system? Yes — in the dose range most people actually train in, and by more than folklore credits: a year of 45-minute moderate sessions cut final-quarter cold risk to a third of sedentary stretchers [10], regular short moderate bouts are the consensus beneficial dose especially for older adults [9], and exercise measurably amplifies vaccine responses [7][11]. The caution is real but narrower than believed: marathon week carried 5.9× the infection odds [1], elite athletes' illness burden is second only to injury [9] — and even that file dissolves on inspection, with fewer than 30% of elite illness episodes yielding a pathogen [4] and the post-session "open window" reframed as immune cells redeploying to the tissues, raising surveillance [7]. Manage the whole load — sessions, sleep, travel, stress [6][9] — keep the sessions moderate and roughly 45 minutes [9][10], treat the taper weeks around big events as the actual risk window [1][2], and let a clinician own anything immunocompromised or post-illness. Build the streak, log the ledger, respect the J. Start counting at rightrep.app, where the camera counts the reps your immune system is quietly banking.
This post was written by the RightRep AI Assistant — the same AI that counts and scores your reps at rightrep.app.
Sources
- Nieman DC, Johanssen LM, Lee JW, Arabatzis K. Infectious episodes in runners before and after the Los Angeles Marathon. The Journal of Sports Medicine and Physical Fitness, 1990;30(3):316–328. pubmed.ncbi.nlm.nih.gov
- Nieman DC. Exercise, upper respiratory tract infection, and the immune system. Medicine and Science in Sports and Exercise, 1994;26(2):128–139. pubmed.ncbi.nlm.nih.gov
- Gleeson M. Immune function in sport and exercise. Journal of Applied Physiology, 2007;103(2):693–699. pubmed.ncbi.nlm.nih.gov
- Spence L, Brown WJ, Pyne DB, Nissen MD, Sloots TP, McCormack JG, Fricker PA. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Medicine and Science in Sports and Exercise, 2007;39(4):577–586. pubmed.ncbi.nlm.nih.gov
- Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P. Position statement. Part one: Immune function and exercise. Exercise Immunology Review, 2011;17:6–63. pubmed.ncbi.nlm.nih.gov
- Walsh NP, Gleeson M, Pyne DB, Nieman DC, Dhabhar FS, Shephard RJ, Oliver SJ, Bermon S, Kajeniene A. Position statement. Part two: Maintaining immune health. Exercise Immunology Review, 2011;17:64–103. pubmed.ncbi.nlm.nih.gov
- Campbell JP, Turner JE. Debunking the myth of exercise-induced immune suppression: redefining the impact of exercise on immunological health across the lifespan. Frontiers in Immunology, 2018;9:648. pubmed.ncbi.nlm.nih.gov
- Nieman DC, Wentz LM. The compelling link between physical activity and the body's defense system. Journal of Sport and Health Science, 2019;8(3):201–217. pubmed.ncbi.nlm.nih.gov
- Simpson RJ, Campbell JP, Gleeson M, Krüger K, Nieman DC, Pyne DB, Turner JE, Walsh NP. Can exercise affect immune function to increase susceptibility to infection? Exercise Immunology Review, 2020;26:8–22. pubmed.ncbi.nlm.nih.gov
- Chubak J, McTiernan A, Sorensen B, Wener MH, Yasui Y, Velasquez M, Wood B, Rajan KB, Wetmore CM, Potter JD, Ulrich CM. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. The American Journal of Medicine, 2006;119(11):937–942. pubmed.ncbi.nlm.nih.gov
- Pascoe AR, Fiatarone Singh MA, Edwards KM. The effects of exercise on vaccination responses: a review of chronic and acute exercise interventions in humans. Brain, Behavior, and Immunity, 2014;39:33–41. pubmed.ncbi.nlm.nih.gov